All Stories

  1. Diamond Sign in Calpainopathy
  2. Global, regional, and national burden of headache disorders, 1990–2021, with forecasts to 2050: A Global Burden of Disease study 2021
  3. Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019
  4. Motor and Non-motor Neurologic Symptoms of Wilson’s Disease: Exploring the Associations
  5. Success of anti-amyloid therapy answers few but raises many questions
  6. Progressive Supranuclear Palsy in India: Past, Present, and Future
  7. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  8. Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021
  9. Exome sequencing identifiesABCA7as an important gene for familial AD cases from Eastern India
  10. Mental health problems raise the odds of cognitive impairment in COVID-19 survivors
  11. An Effort to Identify Genetic Determinants in Siblings With Wilson Disease Manifesting Striking Clinical Heterogeneity: An Exome Profiling Study of Two Indian Families
  12. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  13. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  14. Global Health Trends 1950–2021: Impact of COVID-19 on Mortality and Population Growth
  15. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
  16. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
  17. Analysis of Semiology, Lesion Topography and Treatment Outcomes: A Prospective Study on Post Thalamic Stroke Holmes Tremor
  18. Illiterate Addenbrooke’s Cognitive Examination-III in Three Indian Languages: An Adaptation and Validation Study
  19. Reply to Kljajevic's “Increasing sensitivity of clinical proverb tests for diagnosis of dementia”
  20. Post-Infective Rhombencephalitis with Bilateral Olivary Hypertrophic Degeneration
  21. Unfurling a case of encephalitis with Acanthamoeba after a near-drowning event
  22. A rare case of Uner-Tan syndrome with incidentally detected choroid plexus papilloma
  23. The Genetic Drivers of Juvenile, Young, and Early‐Onset Parkinson's Disease in India
  24. Genetic Variations and Altered Blood mRNA Level of Circadian Genes and BDNF as Risk Factors of Post-Stroke Cognitive Impairment Among Eastern Indians
  25. Arg4810Lys mutation in RNF213 among Eastern Indian non-MMD ischemic stroke patients: a genotype–phenotype correlation
  26. The scope of using pragmatic language tests for early detection of dementia: A systematic review of investigations using figurative language
  27. Genetic Variations and Altered Blood mRNA Level of Circadian Genes and BDNF as Risk Factors of Post-Stroke Cognitive Impairment among Eastern Indians
  28. Evaluation ofApolipoprotein e4allele as susceptible factor for neurodegenerative diseases among Eastern Indians
  29. The genetic drivers of juvenile, young, and early-onset Parkinson’s Disease in India
  30. South Asian medical cohorts reveal strong founder effects and high rates of homozygosity
  31. Arg4810Lys Mutation in RNF213 among Eastern Indian Non-MMD Ischemic Stroke Patients: A Genotype-Phenotype Correlation
  32. Limb to Cranial Overflow Dystonia in a Patient After Stroke
  33. An Indian Young-onset Dementia With Parkinsonism With Double Heterozygous Mutations in ABCA7 and PRKN Identified Through Whole-exome Sequencing
  34. Gastrointestinal, Respiratory, and Olfactory Neurotropism Of Sars-Cov2 as a Possible Trigger of Parkinson’s Disease
  35. Brain-enriched miR-128: Reduced in exosomes from Parkinson’s patient plasma, improves synaptic integrity, and prevents 6-OHDA mediated neuronal apoptosis
  36. Charcot Arthropathy of Elbow Joint in Syringomyelia
  37. Cognitive Stimulation Therapy as an Adjunctive Treatment for Mild to Moderate Dementia
  38. Melatonin in Combination with Pramipexole Treatment Can Reduce the Progression of Rotenone-Induced Parkinsonism in Rats
  39. Adrenocorticotropic Hormone-Induced Dyskinesia and Probable Sudden Unexpected Death in an Infant with Early Infantile Developmental and Epileptic Encephalopathy—Infantile Epileptic Spasm Syndrome Overlap
  40. Pragmatic deficits in patients with schizophrenia and right hemisphere damage: A pilot study
  41. Exosome-derived miR-128 is decreased in Parkinson’s patient plasma that maintains synaptic integrity and protects against both intrinsic and extrinsic pathways of neuronal apoptosis in models of Parkinson’s disease
  42. Genome‐Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India
  43. Adaptation and Validation of Addenbrooke’s Cognitive Examination-III in Bengali for Screening MCI and Dementia
  44. Health status of persons with dementia and caregivers’ burden during the second wave of COVID-19 pandemic: an Indian study
  45. Cognitive Profile of Large-Vessel Vascular Dementia—An Observational Study from a Tertiary Care Center in Kolkata
  46. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
  47. Exploring caregiver burden and health condition of dementia patients during lockdown due to COVID-19 pandemic
  48. Parakinesia Brachialis Oscitans – a Rare Post-Stroke Phenomenon
  49. Gait Apraxia with Exaggerated Upper Limb Movements as Presentation of AARS2 Related Leukoencephalopathy
  50. An online survey on stress, anxiety, and depression in terminal batch students of 2020 during lockdown due to COVID-19 pandemic
  51. CSF P-tau 231 as biomarker in alzheimer's disease
  52. Comparative Study of Risk Factors and Cognitive Profile of Small- and Large-Vessel Vascular Dementia – A Clinic Based Study
  53. Evaluation of non-motor symptoms in wilson disease using the parkinson's disease nonmotor symptoms questionnaire: A pilot cross-sectional study and critical assessment
  54. Correlation of ATP7B gene mutations with clinical phenotype and radiological features in Indian Wilson disease patients
  55. ApoE ε4 and IL-6-174G/C Polymorphism may Lead to Early Onset of Alzheimer's Disease with Atypical Presentation
  56. Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory Study
  57. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990–2019
  58. Perception about Etiology of Epilepsy and Help-Seeking Behavior in Patients with Epilepsy
  59. Behavioral variations among vascular cognitive impairment subtypes – A comparative study
  60. A comparison of cognitive performances between neuromyelitis optica spectrum disorder and multiple sclerosis patients in Indian context
  61. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation
  62. Anti-MOG antibody associated long segment myelitis presenting as anterior cord syndrome
  63. Ataxia and Myoclonus with a Cherry-Red Spot Unfurling an Unusual Phenotypic Presentation of Sialidosis Type 1
  64. Identification of GBA mutations among neurodegenerative disease patients from eastern India
  65. Clinical Study of 668 Indian Subjects with Juvenile, Young, and Early Onset Parkinson’s Disease
  66. A study of Mutation in ATP7B gene and its correlation with clinical phenotype and radiological features in Wilson Disease patients
  67. Predicting Long‐Term Outcome of Patients of Early Parkinsonism with Acute Levodopa Challenge Test
  68. Spectrum of Anti-NMDA Receptor Antibody Encephalitis: Clinical Profile, Management and Outcomes
  69. Effect of COVID-19 related lockdown on nonmotor symptoms of Parkinson's Disease
  70. Non-motor features of amyotrophic lateral sclerosis: A clinic-based study
  71. Global mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019
  72. The Burden of Dementia due to Down Syndrome, Parkinson’s Disease, Stroke, and Traumatic Brain Injury: A Systematic Analysis for the Global Burden of Disease Study 2019
  73. Burden of nonmotor symptoms in Parkinson’s disease patients from eastern India
  74. Mapping routine measles vaccination in low- and middle-income countries
  75. A Comparative Study of the Behavioral Profile of the Behavioral Variant of Frontotemporal Dementia and Parkinson’s Disease Dementia
  76. Difference of PCA from typical AD and amnestic MCI
  77. Charcot-Marie-Tooth disease type 4J with spastic quadriplegia, epilepsy and global developmental delay: a tale of three siblings
  78. Rabbit syndrome in anti-NMDAR antibody encephalitis: a unique association
  79. Subnational mapping of under-5 and neonatal mortality trends in India: the Global Burden of Disease Study 2000–17
  80. Spectrum of anti-myelin oligodendrocyte glycoprotein antibody (MOG-Ab)-associated diseases: an Indian perspective
  81. “Clinical profile of genetically proven huntington's disease patients from eastern india”
  82. Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism
  83. Young-onset sporadic Creutzfeldt–Jakob disease with atypical phenotypic features: a case report
  84. Serum 24‐hydroxycholesterol in probable Alzheimer's dementia: Reexploring the significance of a tentative Alzheimer's disease biomarker
  85. Wilson's disease: a cognitive neuropsychological perspective
  86. In Unexplained Altered Sensorium - Look for Arterial Ammonia Level
  87. A study on short term outcome of stroke in a rural tertiary care center of Sub Himalayan Terai
  88. Epidemiology of Parkinson’s Disease
  89. Behavioural and Psychological Symptoms of Dementia: Correlates and Impact on Caregiver Distress
  90. Rare Intronic Variations in TP73 Gene Found in Patients with Alzheimer’s Disease
  91. Role of Pro-Inflammatory Cytokines and Vitamin D in Probable Alzheimer's Disease with Depression
  92. Reply #2 to: Glycemic Choreoballism
  93. Irreversible Hemichorea–Hemiballism in a Case of Nonketotic Hyperglycemia Presenting as the Initial Manifestation of Diabetes Mellitus
  94. ROLE OF VITAMIN D SIGNALING IN SPORADIC ALZHEIMER’S DISEASE: A CLINICO-EXPERIMENTAL STUDY
  95. Epidemiology of dementia and its burden in the city of Kolkata, India
  96. Development of Bengali Audio–Visual Test Battery for Assessment of Pragmatic Skills: Preliminary Normative Data Based on Educational Level
  97. Study of visuospatial skill in patients with dementia
  98. Spinocerebellar ataxia type 6 in eastern India: Some new observations
  99. Gut dysfunction in Parkinson's disease
  100. Cognitive impairment in idiopathic Parkinson's disease
  101. Alzheimer and Parkinson’s Disease -Two Faces of the Same Disease?
  102. Sporadic and familial myoclonic dystonia: Report of three cases and review of literature
  103. Epilepsy patients with malformations of cortical development: Experience from a tertiary care centre in Eastern India
  104. Genetic and clinical profile of patients of Duchenne muscular dystrophy: Experience from a tertiary care center in Eastern India
  105. Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-κB Connection
  106. Retrobulbar optic neuropathy secondary to isolated sphenoid sinus disease
  107. Author′s response on "Neuropsychiatric profiles in patients with Alzheimer′s disease and vascular dementia"
  108. Therapy of NMO spectrum disorders
  109. Bangur Institute of Neurosciences: One of the premier neurology/neurosurgery teaching institutes of the country
  110. Metabolic Risk Factors of Sporadic Alzheimer's Disease: Implications in the Pathology, Pathogenesis and Treatment
  111. Altered Serum Levels of Adipokines and Insulin in Probable Alzheimer's Disease
  112. Raised Serum Proinflammatory Cytokines in Alzheimer's Disease with Depression
  113. Clinical features, MRI brain, and MRS abnormalities of drug-naοve neurologic Wilson′s disease
  114. Clinical profile and genetic correlation of patients with spinocerebellar ataxia: A study from a tertiary care centre in Eastern India
  115. Neuropsychiatric profiles in patients with Alzheimer′s disease and vascular dementia
  116. Adrenomyeloneuropathy with bulbar palsy: A rare association
  117. Visual Manifestations in Alzheimer’s disease
  118. Genetic study on frontotemporal lobar degeneration in India
  119. Case series of probable sporadic Creutzfeldt-Jakob disease from Eastern India
  120. Seizure, spinal schwannoma, peripheral neuropathy and pulmonary stenosis - A rare combination in a patient of Neurofibromatosis 1
  121. Chapter-14 Dementia in Parkinson�s Disease
  122. Neurological disorders in children and adolescents
  123. Dysarthric Bengali speech: A neurolinguistic study
  124. Community survey of primary dystonia in the city of Kolkata, India
  125. An epidemiologic study of mild cognitive impairment in Kolkata, India
  126. A Prospective Community-Based Study of Stroke in Kolkata, India
  127. 0704 Prevalence of mild cognitive impairment — A population based study in the city of Kolkata